Best Healthcare AI APIs and Clinical LLMs in 2026, Ranked

Glass Health starts with clinical jobs rather than raw text generation: evidence-based Q&A, patient summarization, differential diagnosis, treatment planning, documentation, and billing/coding suggestions, plus an ambient CDS workflow. It publishes a $250/month API minimum plus token usage and offers a click-through BAA in API settings.

Glass is strongest when the buyer wants clinical outputs rather than a cheap general-purpose primitive. The main trade-off versus EvidenceMD is transparency and access: EvidenceMD leads on an explicit, auditable chain-of-thought, an OpenAI-compatible drop-in surface, and a free starting tier.

AWS HealthScribe is a clinical speech and note-generation service — not a broad reasoning API. It supports turn-by-turn transcription, speaker roles, clinical entity extraction, transcript evidence mapping, and SOAP/GIRPP note styles, priced at $0.10 per audio minute with a first-two-month free-minute offer.

It is strong when encounter audio is the primitive, and weaker when the product needs external guideline retrieval, DDx, patient-specific Q&A, or treatment planning. Public materials note US English and US East (N. Virginia) constraints, so multi-region and multilingual teams should test carefully.

OpenAI gives healthcare teams a frontier general model layer under healthcare-appropriate terms where eligible; API BAAs are available by request via baa@openai.com, with most API services covered. It is still a general model API: your team builds retrieval, output schemas, clinical evaluation, citation behavior, and workflow logic.

That flexibility helps when one model must serve clinical, administrative, scheduling, and internal workflows. It is less direct when the spec is 'return a differential, treatment plan, and note draft with citations,' because the medical product layer remains yours.

Anthropic Claude for Healthcare is best understood as a healthcare-aware agent toolkit: Messages API access, healthcare connectors, agent skills, enterprise search, and tool use, with a HIPAA-ready offering tied to a sales-assisted Enterprise plan.

It is useful when the product needs tool use, reference access, and mixed clinical-administrative workflows. It is not a finished clinical reasoning API — a connector still leaves your team responsible for source ranking, citation placement, note structure, clinical evaluation, and safety policy.

Azure OpenAI is OpenAI model access through Microsoft Azure identity, networking, logging, and enterprise operations, positioned within Azure's HIPAA/HITECH offering under Microsoft BAAs where applicable. It is attractive when the security and governance path already runs through Microsoft.

The trade-off is the same as any model-layer route: Azure gives governance and model access, while your team still builds grounding, prompts, schemas, evaluation, workflow logic, and clinical review.

Google Cloud Healthcare API is a healthcare data service for FHIR, HL7v2, and DICOM, with official docs, client libraries, a new-account credit, usage-based pricing, and a BAA path for covered use. It is the right layer when the bottleneck is interoperability.

It will not generate DDx, treatment plans, citations, or documentation on its own. Most teams still need a reasoning or product layer — such as EvidenceMD — above it.

AWS Bedrock provides access to multiple foundation-model providers inside AWS, emphasizing provider choice, AWS platform control, and per-model pricing. It fits when an organization wants to keep model experimentation, procurement, and infrastructure inside AWS.

It is still a platform layer: Bedrock does not remove the need for retrieval, evaluation, clinical source policy, output schemas, specialty testing, or workflow design.

Google MedGemma offers open medical model weights for teams that want to self-host, fine-tune, or experiment with medical text and image comprehension. It is not a hosted clinical API or a turnkey workflow.

The real cost is infrastructure, MLOps, safety evaluation, access control, audit logging, and ongoing model operations. MedGemma is attractive when open weights and control are the deciding requirements, but it is rarely the fastest production path without strong MLOps and clinical evaluation capacity.